Search

Author/Creator Pohlmann, Paula

1. 401 Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 with or without immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors. (9th November 2020)

Authors:
Sharma, Manish; Dumbrava, Ecaterina Ileana; Carvajal, Richard; Catenacci, Daniel; Emens, Leisha; Hanna, Glenn; Juric, Dejan; Kang, Yoon-Koo; Lee, Jeeyun; Lee, Keun-Wook; Li, Bob; Moore, Kathleen; Pegram, Mark; Pohlmann, Paula; Rasco, Drew; Spira, Alexander; Tan, Antoinette; Wang, Ding; Ackerman, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A244
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 401 Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 with or without immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors. (9th November 2020)

Authors:
Sharma, Manish; Dumbrava, Ecaterina Ileana; Carvajal, Richard; Catenacci, Daniel; Emens, Leisha; Hanna, Glenn; Juric, Dejan; Kang, Yoon-Koo; Lee, Jeeyun; Lee, Keun-Wook; Li, Bob; Moore, Kathleen; Pegram, Mark; Pohlmann, Paula; Rasco, Drew; Spira, Alexander; Tan, Antoinette; Wang, Ding; Ackerman, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A426
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CTNI-02. TBCRC049: A PHASE II STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF TUCATINIB, TRASTUZUMAB AND CAPECITABINE FOR THE TREATMENT OF LEPTOMENINGEAL METASTASIS IN HER2 POSITIVE BR1AST CANCER. (9th November 2020)

Authors:
Murthy, Rashmi; O'Brien, Barbara; Berry, Donald; Navin, Nicholas; Johnson, Jason; Gule-Monroe, Maria; Leone, Jose; Specht, Jennifer; Melisko, Michelle; Morikawa, Aki; Storniolo, Anna; Brufsky, Adam; Pohlmann, Paula; Park, Deric; Park, Ben; Krop, Ian; Lin, Nancy; Rimawi, Mothaffar; Wolff, Antonio;...
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii41
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. O82 A phase 1 dose escalation study of PRS-343, a HER2/4–1BB bispecific molecule, in patients with HER2-positive malignancies. (15th April 2020)

Authors:
Piha-Paul, Sarina; Bendell, Johanna; Tolcher, Anthony; Hurvitz, Sara; Patnaik, Amita; Shroff, Rachna; Pohlmann, Paula; Zettl, Markus; Hahn, Noah; Krishnamurthy, Anuradha; Duerr, Manuela; Mei, Jian; Aviano, Kayti; Yusuf, Rushdia; Matis, Louis; Olwill, Shane; Bruns, Ingmar; Ku, Geoffrey
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 1
Page Start:
A1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗